PuriBlood Medical
Medical device company founded in 2016 that develops membrane-based blood filtration and cell-separation technologies. Core R&D focuses on zwitterionic surface modification of polymer membranes to improve hemocompatibility and enable selective leukocyte capture. The company produces sterile leukocyte-reduction filters for packed red blood cells, platelets and whole blood, maintains an ISO 13485 quality system and holds multiple regulatory approvals and market authorizations.
Industries
Nr. of Employees
small (1-50)
PuriBlood Medical
Products
Leukocyte reduction filter for packed red blood cells
Filter assembly using coated meltblown nonwoven membrane and transparent housing designed to remove leukocytes from packed red blood cells prior to transfusion.
Leukocyte reduction filter for whole blood
Rigid-housing filter with coated meltblown PBT nonwoven media intended for leukoreduction of fresh whole blood (250 mL and 500 mL variants).
Leukocyte reduction filter for platelets
Filter designed for pooled platelet concentrates using coated meltblown nonwoven media, intended to reduce leukocytes while preserving platelets.
Disposable blood fractionation membrane for pathogen enrichment
Syringe-driven disposable blood fractionation filter intended to deplete nucleated blood cells and concentrate pathogens for downstream microbiology and molecular assays.
Syringe-based leukocyte capture filter for PRP
Disposable syringe filter intended to remove leukocytes from platelet-rich plasma while preserving platelet recovery for therapeutic use.
Syringe-based leukocyte harvest filter for WBC isolation (in development)
Filter variant under development intended to harvest leukocytes (~60% WBC recovery) for downstream cell therapy or cell-culture research.
Leukocyte reduction filter for packed red blood cells
Filter assembly using coated meltblown nonwoven membrane and transparent housing designed to remove leukocytes from packed red blood cells prior to transfusion.
Leukocyte reduction filter for whole blood
Rigid-housing filter with coated meltblown PBT nonwoven media intended for leukoreduction of fresh whole blood (250 mL and 500 mL variants).
Leukocyte reduction filter for platelets
Filter designed for pooled platelet concentrates using coated meltblown nonwoven media, intended to reduce leukocytes while preserving platelets.
Disposable blood fractionation membrane for pathogen enrichment
Syringe-driven disposable blood fractionation filter intended to deplete nucleated blood cells and concentrate pathogens for downstream microbiology and molecular assays.
Syringe-based leukocyte capture filter for PRP
Disposable syringe filter intended to remove leukocytes from platelet-rich plasma while preserving platelet recovery for therapeutic use.
Syringe-based leukocyte harvest filter for WBC isolation (in development)
Filter variant under development intended to harvest leukocytes (~60% WBC recovery) for downstream cell therapy or cell-culture research.
Services
Sample provision and technical support
Provision of product samples on request and technical support for product evaluation and research.
Sample provision and technical support
Provision of product samples on request and technical support for product evaluation and research.
Expertise Areas
- Membrane filtration for leukodepletion
- Surface zwitterionization and biomaterial coatings
- Polymer membrane fabrication (meltblown nonwovens)
- Clinical performance evaluation of blood-contacting devices
Key Technologies
- Zwitterionic surface modification
- Zwitterionic-bias membrane coatings
- Meltblown nonwoven membrane fabrication
- PEGylated hydrogel surface layers